Unknown

Dataset Information

Testosterone replacement therapy in patients with prostate cancer after radical prostatectomy.


ABSTRACT:

Purpose

Testosterone replacement therapy in men with prostate cancer is controversial, with concern that testosterone can stimulate cancer growth. We evaluated the safety and efficacy of testosterone in hypogonadal men with prostate cancer treated with radical prostatectomy.

Materials and methods

We performed a review of 103 hypogonadal men with prostate cancer treated with testosterone after prostatectomy (treatment group) and 49 nonhypogonadal men with cancer treated with prostatectomy (reference group). There were 77 men with low/intermediate (nonhigh) risk cancer and 26 with high risk cancer included in the analysis. All men were treated with transdermal testosterone, and serum hormone, hemoglobin, hematocrit and prostate specific antigen were evaluated for more than 36

SUBMITTER: Pastuszak AW 

PROVIDER: S-EPMC4544840 | biostudies-literature | 2013 Aug

REPOSITORIES: biostudies-literature